Call us today 212-583-0100


Enzo Therapeutics seeks collaborations and partnerships with pharmaceutical and biotechnology companies that will enhance and accelerate drug development and leverage the value of our platform technologies and extensive IP estate.

  • We have assigned a high priority to establishing partnerships for our cell signaling modulation programs.
  • Other programs that show strong promise for therapeutic applications are available for out-licensing. These include our StealthVector® for HIV; AlequelT, for Crohn's disease; and HBV therapy EHT-899, for hepatitis B.

For additional information, please contact: